PAVmed Inc. (PAVM)
NASDAQ: PAVM · Real-Time Price · USD
0.5971
+0.0061 (1.03%)
At close: Jul 3, 2025, 1:00 PM
0.5973
+0.0002 (0.03%)
After-hours: Jul 3, 2025, 4:13 PM EDT
PAVmed Market Cap
PAVmed has a market cap or net worth of $10.52 million as of July 3, 2025. Its market cap has increased by 10.73% in one year.
Market Cap
10.52M
Enterprise Value
16.71M
1-Year Change
10.73%
Ranking
Category
Stock Price
$0.60
Market Cap Chart
Since July 28, 2016, PAVmed's market cap has decreased from $173.00M to $10.52M, a decrease of -93.92%. That is a compound annual growth rate of -26.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2025 | 10.50M | 52.17% |
| Dec 31, 2024 | 6.90M | -79.22% |
| Dec 29, 2023 | 33.20M | -26.22% |
| Dec 30, 2022 | 45.00M | -79.20% |
| Dec 31, 2021 | 216.30M | 95.22% |
| Dec 31, 2020 | 110.80M | 151.25% |
| Dec 31, 2019 | 44.10M | 72.94% |
| Dec 31, 2018 | 25.50M | -19.56% |
| Dec 29, 2017 | 31.70M | -65.47% |
| Dec 30, 2016 | 91.80M | -46.94% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 699.59B |
| Johnson & Johnson | 374.29B |
| AbbVie | 336.94B |
| Novo Nordisk | 309.43B |
| UnitedHealth Group | 279.00B |
| Novartis AG | 243.28B |
| Abbott Laboratories | 233.33B |
| AstraZeneca | 219.33B |